Search research articles
Contact Us
Filters
Showing results (51-60 of 127) with videos related to
Page
of 13
Sort By:
Metabolic Brain Disease
|
February 26, 2021
Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain
Nitish Kumar, Nidhi Sharma, Rishabh Khera, et al.
Indian Journal of Pharmacology
|
February 21, 2019
Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction
Sidharth Mehan, Vikramdeep Monga, Manju Rani, et al.
Neuroscience
|
May 1, 2024
Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Chemico-Biological Interactions
|
April 3, 2023
Protease-activated receptors in kidney diseases: A comprehensive review of pathological roles, therapeutic outcomes and challenges
Newly Bagang, Kirti Gupta, Gaaminepreet Singh, et al.
Neurochemical Research
|
December 30, 2023
Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis
Aradhana Prajapati, Sidharth Mehan, Zuber Khan, et al.
European Journal of Pharmacology
|
August 25, 2009
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor
Rahul Deshmukh, Vivek Sharma, Sidharth Mehan, et al.
Current Molecular Pharmacology
|
April 29, 2020
Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Mamtaj Alam, Rajeshwar K Yadav, Elizabeth Minj, et al.
Journal of Neuroscience Methods
|
March 9, 2025
Enhancing therapeutic efficacy of fingolimod via intranasal delivery in an ethidium bromide-induced model of multiple sclerosis
Anshul Sharma, Nitin Sharma, Kushagra Khanna, et al.
Biochemical Pharmacology
|
September 30, 2023
Melatonin-mediated IGF-1/GLP-1 activation in experimental OCD rats: Evidence from CSF, blood plasma, brain and in-silico investigations
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Molecular Neurobiology
|
April 19, 2022
Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions
Rishabh Khera, Sidharth Mehan, Sumit Kumar, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 127) with videos related to
Sort By:
Page
of 13
Metabolic Brain Disease
|
February 26, 2021
Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain
Nitish Kumar, Nidhi Sharma, Rishabh Khera, et al.
Indian Journal of Pharmacology
|
February 21, 2019
Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction
Sidharth Mehan, Vikramdeep Monga, Manju Rani, et al.
Neuroscience
|
May 1, 2024
Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Chemico-Biological Interactions
|
April 3, 2023
Protease-activated receptors in kidney diseases: A comprehensive review of pathological roles, therapeutic outcomes and challenges
Newly Bagang, Kirti Gupta, Gaaminepreet Singh, et al.
Neurochemical Research
|
December 30, 2023
Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis
Aradhana Prajapati, Sidharth Mehan, Zuber Khan, et al.
European Journal of Pharmacology
|
August 25, 2009
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor
Rahul Deshmukh, Vivek Sharma, Sidharth Mehan, et al.
Current Molecular Pharmacology
|
April 29, 2020
Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Mamtaj Alam, Rajeshwar K Yadav, Elizabeth Minj, et al.
Journal of Neuroscience Methods
|
March 9, 2025
Enhancing therapeutic efficacy of fingolimod via intranasal delivery in an ethidium bromide-induced model of multiple sclerosis
Anshul Sharma, Nitin Sharma, Kushagra Khanna, et al.
Biochemical Pharmacology
|
September 30, 2023
Melatonin-mediated IGF-1/GLP-1 activation in experimental OCD rats: Evidence from CSF, blood plasma, brain and in-silico investigations
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Molecular Neurobiology
|
April 19, 2022
Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions
Rishabh Khera, Sidharth Mehan, Sumit Kumar, et al.
Page
of 13